3September: Pleased as punch to announce I'll be delivering my now-annual "Top 10 U.S. Biopharma Clusters" presentation at the BioHealth Capital Region (BioHealth Cap Region)'s upcoming 2024 Forum set for September 17-18 in Rockville, MD. Look forward to meeting everyone at the event!

Astrocytes Reprogrammed into Brain Stem Cells through Epigenetic Modifications Researchers identified a unique methylation pattern in brain stem cells that could offer a way to reprogram astrocytes to treat nerve damage. Learn more: hubs.li/Q02NPLHZ0

A novel blood test to detect levels of potassium isotopes in the blood could be an effective biomarker for the early detection of Alzheimer's disease. Learn more: hubs.li/Q02NQsqQ0

Lonza completed its planned expansion of the mid-scale microbial manufacturing facility at its Visp, Switzerland site, allowing cGMP manufacturing and release of biologics produced using microbial fermentation. Learn more: hubs.li/Q02NRvBb0

Cyber-Physical System for Better Continuous Bioprocess Control 24/7 production can be a challenge for traditional drug firms says the team behind a new digital mAb processing method. Read more: hubs.li/Q02NRLff0

Follow the Flow for In-Line Analysis A team of researchers concluded that multivariate data analysis can be applied to large data sets to enable deep learning. Read more: hubs.li/Q02NRCWN0

NEW WEBINAR! On 9/12, Dr. Chunping Xu, Senior Director of Chemistry R&D at TriLink BioTechnologies, will provide an overview of mRNA applications in vaccine and therapeutic development. REGISTER: hubs.li/Q02NJVGG0 TriLink BioTech #mRNA

Widespread, opportunistic testing for prostate specific antigen (PSA) could be contributing the overdiagnosis of prostate cancer across Europe, researchers warn. Learn why: hubs.li/Q02NQyzk0

Radiopharmaceuticals Create Fresh Challenges for Manufacturing Radiopharmaceuticals work like radiotherapy but provide localized—rather than external—delivery of a radioisotope. Learn more: hubs.li/Q02NRj420

Bayer and NextRNA Therapeutics will jointly develop two first-in-class small molecule programs targeting long non-coding RNA. The deal is worth $500M+. Read more: hubs.li/Q02NQtjj0

Mpox Protection: Moderna's New mRNA Vaccine May Beat Today's MVA Shot Investigational #mpox #mRNA vaccine, developed by Moderna, reduces disease severity in primates compared to available vaccines. Learn more: hubs.li/Q02NPfYH0

Lentiviral Vector Manufacturing Toolbox Introduced by Rentschler Biopharma Lentiviral vectors (LVVs) are becoming increasingly prominent in the advanced therapy space, according to Rentschler Biopharma. Read more: hubs.li/Q02NRrPx0

Astrocytes Reprogrammed into Brain Stem Cells through Epigenetic Modifications New research into epigenetic changes in astrocytes from scientists at DKFZ and Heidelberg University helps explain how this is possible. Learn more: hubs.li/Q02NRvYD0

$600M+ Credit Firm Targets Life-Sci Companies in Later Stages Symbiotic Capital launches with $600 million-plus in capital, about half of which has been lent to advanced-stage life sciences companies. Read more: hubs.li/Q02NRtmK0

.Recursion’s Ambitions: Developing 100+ Candidates, Joining with Exscientia Chris Gibson, PhD, discusses the company's ambitious plans to develop 100 pipeline candidates in roughly a decade and workforce growth plans. Read more: hubs.li/Q02NPLmh0

Astrocytes Reprogrammed into Brain Stem Cells through Epigenetic Modifications New research into epigenetic changes in astrocytes from scientists at DKFZ and Heidelberg University helps explain how this is possible. Learn more: hubs.li/Q02NPLhB0

NEW WEBINAR! On 9/17, Mu-ming Poo, PhD, Miguel Esteban, PhD, and Jan Mulder will discuss some of the wide-ranging applications of spatial technology. REGISTER now to join us for this free sponsored webinar: hubs.li/Q02NQCq90 #Omics #Cancer

NEW WEBINAR! On 9/19, Dr. Gary Pestano will describe current applications of blood-based Droplet Digital™PCR (ddPCR™) testing in the clinic. Register now to join us for this free webinar sponsored by Bio-Rad Laboratories: hubs.li/Q02NSJDb0 Bio-Rad Life Science

Scientists have uncovered a new cell type in the human brain. They also found non-tumor cells that are neuron-glia hybrids, suggesting that this cell population may contribute to healthy brain function. Read more: hubs.li/Q02NTNX30

Trinity Scientist Wins European Research Grant to Study Brain Repair Michael-John Dolan, PhD, and his team will focus on brain repair as a model system, with the ultimate goal of harnessing microglial states. Learn more: hubs.li/Q02NTPHY0